News of Center PharmaCOVID |
|
V.M. Tsvetov (1), I.S. Burashnikova (2), D.A. Sychev (3), I.V. Poddubnaya (4)
The possibility and prospects of using cytostatics in patients with COVID-19 on the example of cyclophosphamide
|
10-13 |
|
K.B. Mirzaev (1), V.M. Tsvetov (2)
Evaluation of the scientific basis for the use of riamilovir for the treatment of COVID-19
|
14-16 |
|
K.B. Mirzaev (1), D.A. Sychev (2)
Possibility and prospects of using bamlanivimab in patients with COVID-19
|
17-19 |
REVIEWS |
|
M.D. Shakhnazarova (1, 2), N.A. Geppe (1), I.V. Ozerskaya (1), M.M. Chepurnaya (3), S.I. Shatalina (1, 2)
Current possibilities of nebulizer therapy in the treatment of respiratory pathology in children
|
20-26 |
|
Yu.M. Lebedeva (1), M.V. Gmoshinskaya (2), E.A. Pyryeva (2)
Nutrition for preschool and school children: the state of the problem
|
27-33 |
|
M.A. Ufimtseva, K.I. Nikolaeva, D.S. Zhunisova, Yu.M. Bochkarev, A.S. Shubina
The history of the development of telemedicine. Modern information and communication technologies in medicine
|
34-38 |
|
|
V.A. Revyakina, E.D. Kuvshinova
Allergic rhinitis in view of domestic and international documents
|
39-44 |
|
E.P. Karpova, M.P. Emelyanova, D.A. Tulupov
Therapeutic algorithm for the management of children with acute otitis media
|
45-48 |
|
E.E. Lokshina (1), O.V. Zaytseva (1, 2), S.V. Zaytseva (1)
Antibacterial therapy for respiratory tract and ent infections in children - problems and potential solutions
|
49-57 |
|
A.S. Polyakova, M.D. Bakradze, I.L. Mityushin, I.L. Chashchina, A.A. Tkacheva
Typical changes in the lungs of children with covid-19, atypical treatment
|
58-67 |
ORIGINAL ARTICLES |
|
A.A. Tkacheva, A.S. Polyakova, M.D. Bakradze, V.K. Tatochenko, D.S. Yasakov
Community-acquired pneumonia in children
|
68-74 |
|
K.D. Ermolenko (1), T.V. Potapova (2, 3)
Antibiotic resistance of campylobacteria in St. Petersburg
|
76-80 |
|
D.I. Sadykova (1), L.F. Galimova (1, 2), E.S. Slastnikova (1, 2), N.E. Usova (2), Ch.D. Khaliullina (1)
Analysis of adherence to statin therapy among children with familial hypercholesterolemia: results of a 3-year prospective study
|
81-85 |
|
P.B. Khishtilova, D.F. Sergienko
Influence of various factors on the formation of outcomes of bronchopulmonary dysplasia in children
|
86-90 |
|
M.I. Dubrovskaya, E.I. Gryaznova, A.S. Botkina
The type of psychological component of the mother’s gestational dominant and the severity of functional gastrointestinal disorders in children of the first year of life: results of an online survey
|
91-97 |
|
D.F. Sergienko, P.B. Khishtilova
Matrix metalloproteinase-9 in age-related transformation of bronchopulmonary dysplasia in children
|
98-101 |
|
P.V. Slukin (1), N.K. Fursova (1), I.V. Kukes (2, 3), N.I. Briko (4)
Evaluation of the ability of benzydamine hydrochloride to inhibit planktonic cells, as well as growing and mature biofilms of clinically important microorganisms
|
102-107 |
|
|
I.A. Dronov (1, 2), N.D. Odinayeva (2, 3)
Rational treatment of acute respiratory tract infections in children as a method of antimicrobial resistance control: focus on phytotherapy
|
108-114 |
|
A.N. Radtsig
Choice of topical decongestant for symptomatic treatment of nasal obstruction
|
115-118 |
|
B.N. Gamayunov
Modern possibilities of combined external therapy in dermatological practice
|
119-123 |
Русский
